Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$104.97
-1.36-1.28%
At close: -
$104.00
-0.97-0.92%
After Hours: 6:34 PM EDT
Comments
Loading...
BioNTech Analyst Ratings and Price Targets | NASDAQ:BNTX | Benzinga
BioNTech SE has a consensus price target of $140.61 based on the ratings of 21 analysts. The high is $171.44 issued by Canaccord Genuity on March 11, 2025. The low is $110 issued by Goldman Sachs on May 29, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Truist Securities on June 16, 2025, June 5, 2025, and June 3, 2025, respectively. With an average price target of $146 between HC Wainwright & Co., HC Wainwright & Co., and Truist Securities, there's an implied 40.38% upside for BioNTech SE from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Truist Securities
Goldman Sachs
JP Morgan
Citigroup
1calculated from analyst ratings
Analyst Ratings for BioNTech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/16/2025 | Buy Now | 32.69% | HC Wainwright & Co. | Robert Burns46% | $145 → $138 | Maintains | Buy | Get Alert |
| 06/05/2025 | Buy Now | 39.42% | HC Wainwright & Co. | Robert Burns46% | $134 → $145 | Maintains | Buy | Get Alert |
| 06/03/2025 | Buy Now | 49.04% | Truist Securities | Asthika Goonewardene42% | $151 → $155 | Reiterates | Buy → Buy | Get Alert |
| 05/29/2025 | Buy Now | 5.77% | Goldman Sachs | Asad Haider 60% | → $110 | Initiates | → Neutral | Get Alert |
| 05/22/2025 | Buy Now | 11.54% | JP Morgan | Jessica Fye66% | $120 → $116 | Maintains | Neutral | Get Alert |
| 05/22/2025 | Buy Now | 28.85% | HC Wainwright & Co. | Robert Burns46% | $134 → $134 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2025 | Buy Now | 28.85% | HC Wainwright & Co. | Robert Burns46% | $145 → $134 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 34.62% | Citigroup | Geoff Meacham62% | $145 → $140 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 26.92% | Morgan Stanley | Terence Flynn66% | $140 → $132 | Maintains | Overweight | Get Alert |
| 04/01/2025 | Buy Now | 39.42% | HC Wainwright & Co. | Robert Burns46% | $150 → $145 | Maintains | Buy | Get Alert |
| 03/13/2025 | Buy Now | 39.42% | Citigroup | Geoff Meacham62% | → $145 | Initiates | → Buy | Get Alert |
| 03/11/2025 | Buy Now | 33.65% | Morgan Stanley | Terence Flynn66% | $145 → $139 | Maintains | Overweight | Get Alert |
| 03/11/2025 | Buy Now | 64.85% | Canaccord Genuity | John Newman45% | $171.44 → $171.44 | Maintains | Buy | Get Alert |
| 03/11/2025 | Buy Now | 37.5% | BMO Capital | Etzer Darout48% | $130 → $143 | Maintains | Outperform | Get Alert |
| 01/10/2025 | Buy Now | 65.38% | Truist Securities | Asthika Goonewardene42% | → $172 | Initiates | → Buy | Get Alert |
| 12/11/2024 | Buy Now | 63.46% | Wells Fargo | Mohit Bansal68% | → $170 | Initiates | → Overweight | Get Alert |
| 11/27/2024 | Buy Now | 64.85% | Canaccord Genuity | William Maughan71% | $171 → $171.44 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | 17.31% | JP Morgan | Jessica Fye66% | $124 → $122 | Maintains | Neutral | Get Alert |
| 11/19/2024 | Buy Now | 20.19% | Evercore ISI Group | Cory Kasimov66% | $110 → $125 | Upgrade | In-Line → Outperform | Get Alert |
| 11/18/2024 | Buy Now | 64.42% | Canaccord Genuity | John Newman45% | $171 → $171 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 44.23% | HC Wainwright & Co. | Robert Burns46% | $150 → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 64.42% | Canaccord Genuity | John Newman45% | $171 → $171 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 31.73% | Goldman Sachs | Chris Shibutani55% | $90 → $137 | Upgrade | Neutral → Buy | Get Alert |
| 11/06/2024 | Buy Now | 17.31% | TD Cowen | Yaron Werber37% | $132 → $122 | Maintains | Hold | Get Alert |
| 11/05/2024 | Buy Now | 17.31% | TD Cowen | Yaron Werber37% | $132 → $122 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 19.23% | JP Morgan | Jessica Fye66% | $125 → $124 | Maintains | Neutral | Get Alert |
| 10/07/2024 | Buy Now | 30.77% | HSBC | Yifeng Liu36% | $97 → $136 | Maintains | Buy | Get Alert |
| 10/07/2024 | Buy Now | 44.23% | HC Wainwright & Co. | Robert Burns46% | $113 → $150 | Maintains | Buy | Get Alert |
| 09/24/2024 | Buy Now | 39.42% | Morgan Stanley | Terence Flynn66% | $93 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/19/2024 | Buy Now | 44.23% | Deutsche Bank | Emmanuel Papadakis48% | $95 → $150 | Maintains | Buy | Get Alert |
| 09/18/2024 | Buy Now | 25.96% | UBS | Eliana Merle49% | $97 → $131 | Maintains | Neutral | Get Alert |
| 09/17/2024 | Buy Now | 44.23% | Jefferies | Akash Tewari44% | $96 → $150 | Upgrade | Hold → Buy | Get Alert |
| 09/16/2024 | Buy Now | 20.19% | JP Morgan | Jessica Fye66% | $91 → $125 | Upgrade | Underweight → Neutral | Get Alert |
| 09/16/2024 | Buy Now | 44.23% | B of A Securities | Tazeen Ahmad56% | $125 → $150 | Maintains | Buy | Get Alert |
| 09/16/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2024 | Buy Now | -7.69% | Jefferies | Akash Tewari44% | $90 → $96 | Maintains | Hold | Get Alert |
| 08/27/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 08/19/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | -12.5% | JP Morgan | Jessica Fye66% | $94 → $91 | Maintains | Underweight | Get Alert |
| 08/07/2024 | Buy Now | -8.65% | Deutsche Bank | Emmanuel Papadakis48% | $95 → $95 | Upgrade | Hold → Buy | Get Alert |
| 08/06/2024 | Buy Now | -18.27% | TD Cowen | Yaron Werber37% | $98 → $85 | Maintains | Hold | Get Alert |
| 08/01/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2024 | Buy Now | -9.62% | JP Morgan | Jessica Fye66% | $90 → $94 | Maintains | Underweight | Get Alert |
| 06/10/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/28/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | -3.85% | Evercore ISI Group | Cory Kasimov66% | → $100 | Initiates | → In-Line | Get Alert |
| 05/08/2024 | Buy Now | 8.65% | HC Wainwright & Co. | Robert Burns46% | $107 → $113 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -5.77% | TD Cowen | Yaron Werber37% | $95 → $98 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | 17.31% | BMO Capital | Etzer Darout48% | $123 → $122 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 2.88% | HC Wainwright & Co. | Robert Burns46% | $107 → $107 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | -2.88% | UBS | Eliana Merle49% | $110 → $101 | Maintains | Neutral | Get Alert |
| 03/22/2024 | Buy Now | -13.46% | JP Morgan | Jessica Fye66% | $99 → $90 | Maintains | Underweight | Get Alert |
| 03/21/2024 | Buy Now | 64.42% | Canaccord Genuity | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | Buy Now | 18.27% | BMO Capital | Etzer Darout48% | $127 → $123 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | -3.85% | Goldman Sachs | Chris Shibutani55% | $113 → $100 | Maintains | Neutral | Get Alert |
| 02/23/2024 | Buy Now | 64.42% | Canaccord Genuity | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 02/23/2024 | Buy Now | 22.12% | BMO Capital | Etzer Darout48% | → $127 | Initiates | → Outperform | Get Alert |
| 02/21/2024 | Buy Now | 64.42% | Canaccord Genuity | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2024 | Buy Now | 64.42% | Canaccord Genuity | John Newman45% | $168 → $171 | Maintains | Buy | Get Alert |
| 01/23/2024 | Buy Now | 2.88% | HC Wainwright & Co. | Robert Burns46% | $133 → $107 | Maintains | Buy | Get Alert |
| 12/01/2023 | Buy Now | -4.81% | JP Morgan | Jessica Fye66% | $106 → $99 | Downgrade | Neutral → Underweight | Get Alert |
| 11/27/2023 | Buy Now | 27.88% | HC Wainwright & Co. | Robert Burns46% | → $133 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | Buy Now | 27.88% | HC Wainwright & Co. | Robert Burns46% | $180 → $133 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 6.73% | Morgan Stanley | Matthew Korn45% | $110 → $111 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 5.77% | Morgan Stanley | Matthew Korn45% | $116 → $110 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | 6.73% | HSBC | Yifeng Liu36% | $124 → $111 | Downgrade | Buy → Hold | Get Alert |
| 08/28/2023 | Buy Now | 73.08% | HC Wainwright & Co. | Robert Burns46% | → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | Buy Now | 73.08% | HC Wainwright & Co. | Robert Burns46% | $181 → $180 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 11.54% | Morgan Stanley | Matthew Korn45% | $119 → $116 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | Buy Now | 14.42% | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | 14.42% | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | Buy Now | 14.42% | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | Buy Now | 14.42% | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/14/2023 | Buy Now | 19.23% | HSBC | Rajesh Kumar61% | → $124 | Initiates | → Buy | Get Alert |
| 07/11/2023 | Buy Now | 14.42% | Morgan Stanley | Matthew Korn45% | $124 → $119 | Maintains | Equal-Weight | Get Alert |
| 06/26/2023 | Buy Now | 19.23% | Morgan Stanley | Matthew Korn45% | $124 → $124 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/20/2023 | Buy Now | 19.23% | Morgan Stanley | Matthew Korn45% | → $124 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/16/2023 | Buy Now | 95.19% | Canaccord Genuity | John Newman45% | $203 → $203 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | Buy Now | 19.23% | Morgan Stanley | Matthew Korn45% | → $124 | Reiterates | → Equal-Weight | Get Alert |
| 06/09/2023 | Buy Now | 74.04% | HC Wainwright & Co. | Robert Burns46% | → $181 | Reiterates | → Buy | Get Alert |
| 06/01/2023 | Buy Now | 74.04% | HC Wainwright & Co. | Robert Burns46% | $198 → $181 | Maintains | Buy | Get Alert |
| 05/23/2023 | Buy Now | 90.38% | HC Wainwright & Co. | Robert Burns46% | $210 → $198 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | 15.38% | Deutsche Bank | Emmanuel Papadakis48% | $135 → $120 | Maintains | Hold | Get Alert |
| 05/17/2023 | Buy Now | 63.46% | Redburn Partners | Simon Baker27% | $165 → $170 | Upgrade | Neutral → Buy | Get Alert |
| 05/09/2023 | Buy Now | 19.23% | Morgan Stanley | Matthew Korn45% | $150 → $124 | Maintains | Equal-Weight | Get Alert |
| 04/24/2023 | Buy Now | 29.81% | Deutsche Bank | Emmanuel Papadakis48% | $160 → $135 | Maintains | Hold | Get Alert |
| 04/10/2023 | Buy Now | 23.08% | JP Morgan | Jessica Fye66% | $142 → $128 | Maintains | Neutral | Get Alert |
| 03/31/2023 | Buy Now | 47.12% | UBS | Eliana Merle49% | $168 → $153 | Maintains | Neutral | Get Alert |
| 03/30/2023 | Buy Now | 101.92% | HC Wainwright & Co. | Robert Burns46% | → $210 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | Buy Now | 95.19% | Canaccord Genuity | William Maughan71% | $191 → $203 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | 25% | TD Cowen | Yaron Werber37% | $145 → $130 | Maintains | Market Perform | Get Alert |
| 03/28/2023 | Buy Now | 86.54% | B of A Securities | Tazeen Ahmad56% | $239 → $194 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | 44.23% | Morgan Stanley | Matthew Korn45% | $216 → $150 | Maintains | Equal-Weight | Get Alert |
| 03/28/2023 | Buy Now | 34.62% | Goldman Sachs | Chris Shibutani55% | $156 → $140 | Maintains | Neutral | Get Alert |
| 03/23/2023 | Buy Now | 101.92% | HC Wainwright & Co. | Robert Burns46% | $272 → $210 | Maintains | Buy | Get Alert |
FAQ
What is the target price for BioNTech (BNTX) stock?
The latest price target for BioNTech (NASDAQ:BNTX) was reported by HC Wainwright & Co. on June 16, 2025. The analyst firm set a price target for $138.00 expecting BNTX to rise to within 12 months (a possible 32.69% upside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioNTech (BNTX)?
The latest analyst rating for BioNTech (NASDAQ:BNTX) was provided by HC Wainwright & Co., and BioNTech maintained their buy rating.
When was the last upgrade for BioNTech (BNTX)?
The last upgrade for BioNTech SE happened on November 19, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for BioNTech SE.
When was the last downgrade for BioNTech (BNTX)?
The last downgrade for BioNTech SE happened on December 1, 2023 when JP Morgan changed their price target from $106 to $99 for BioNTech SE.
When is the next analyst rating going to be posted or updated for BioNTech (BNTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioNTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioNTech was filed on June 16, 2025 so you should expect the next rating to be made available sometime around June 16, 2026.
Is the Analyst Rating BioNTech (BNTX) correct?
While ratings are subjective and will change, the latest BioNTech (BNTX) rating was a maintained with a price target of $145.00 to $138.00. The current price BioNTech (BNTX) is trading at is $104.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
